Purple Book


Also found in: Medical.

Purple Book

(publication)
The "System V Interface Definition". The covers of the first editions were an amazingly nauseating shade of off-lavender.

Purple Book

(publication)
The Wizard Book.

See also book titles.
References in periodicals archive ?
1520, the Purple Book Continuity Act of 2019: These two bipartisan bills will increase the accuracy and transparency of the Food and Drug Administration databases that generic and biosimilar manufacturers depend on to bring more affordable prescription drugs to market.
House Resolution 1520, Purple Book Continuity Act of 2019: The Purple Book is a less transparent and, ultimately, less helpful data source of the patents and exclusivities related to biologics.
The Pension Protection Fund '2017 Purple Book' stated that at that time there were 10.5 million members of defined benefit - often known as final salary - pensions, of which 40 per cent were in payment.
Classes can be found by checking the fiscal year 2016 course catalog, also known as the Purple Book, at <http:/ulc.usace/army.mil/downloads/purplebook2016.pdf>.
And although at the time this was seen as being an argument between different factions, who were all producing their own pamphlets--the Blue Labour e-book, the Purple Book, and Labour's Future from Soundings--in fact there was quite a lot of similarity between them in terms of their analysis.
She shouts, "Damn you Cole Seatstone!" throwing a thin purple book at his head.
New Labour also flirted with purple under Tony Blair - which explains the title of the Purple Book, a collection of essays by party members associated with the Blairite wing.
CLP is based on the Globally Harmonised System for the Classification and Labelling of Chemicals (GHS), a worldwide hazard communication system that was first published in 2003--the so-called Purple Book. The GHS is updated every 2 years and is now up to its 5th revised edition, even before the new requirements apply to mixtures here.
That was demonstrated through a number of developments: The FDA accepted the first biosimilar applications; the regulatory agency published the all-new "purple book," listing biologic drug patents, exclusivities and future interchangeable products; the nation witnessed the first-ever appel late court case involving a biosimilar application; and the FDA's oncologic drugs advisory committee voted unanimously to recommend the approval of filgrastim.
The FDA published its first edition of the 'Purple Book', the biosimilar version of the Agency's Orange Book.
The same may hold true for a biosimilar depending on the data package and level of similarity as laid out in Exhibit B.The FDA also created the purple book in September this year.
In relation to this, FDA have just launched (September 9) what they call the "Purple Book".